A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia

Cancer Research

Volumn 65, Issue 1, 2005, Pages 291-299

  Fine, Bernard M ^a,b   Kaspers, Gertjan J L ^c   Ho, Minh ^a   Loonen, Anne H ^c   Boxer, Linda M ^a,b  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ASPARAGINASE; ASPARTATE AMMONIA LIGASE; CCAAT ENHANCER BINDING PROTEIN; COMPLEMENTARY DNA; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; AMINO ACID METABOLISM; ANIMAL CELL; ARTICLE; DNA MICROARRAY; DOSE RESPONSE; ENHANCER REGION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC ASSOCIATION; GENOME ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RNA TRANSCRIPTION; SAMPLING;

ADOLESCENT; ANTINEOPLASTIC AGENTS; ARTIFICIAL GENE FUSION; ASPARAGINASE; CELL LINE, TUMOR; CHILD; FEMALE; GENOME, HUMAN; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; MALE; RECURRENCE; TRANSLOCATION, GENETIC;

EID: 11244314360     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Pui CH, Evans WE. Acute lymphoblastic leukemia. N Engl J Med 1998;339:605-15.
2. Kaspers GJ, Veerman AJ, Pieters R, et al. In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 1997;90:2723-9.
3. Asselin BL, Kreissman S, Coppola DJ, et al. Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 1999;21:6-12.
4. Chesson BD. Miscellaneous Chemotherapeutic agents. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology. 6th ed. Philadelphia: Lippincott Williams & Wilkins: 2001. p. 452.
5. Haskell CM, Canellos GP. L-Asparaginase resistance in human leukemia-asparagine synthetase. Biochem Pharmacol 1969;18:2578-80.
6. Aslanian AM, Fletcher BS, Kilberg MS. Asparagine synthetase expression alone is sufficient to induce L-asparaginase resistance in MOLT-4 human leukaemia cells. Biochem J 2001;357:321-8.
7. Peng H, Shen N, Qian L, et al. Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells. Br J Cancer 2001;85:930-5.
8. Dubbers A, Wurthwein G, Muller HJ, et al. Asparagine synthetase activity in paediatric acute leukaemias: AML-M5 subtype shows lowest activity. Br J Haematol 2000;109:427-9.
9. Stams WA, den Boer ML, Beverloo HB, et al. Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. Blood 2003;101:2743-7.
10. Pieters R, Loonen AH, Huismans DR, et al. In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. Blood 1990;76:2327-36.
11. Kaspers GJ, Kardos G, Pieters R, et al. Different cellular drug resistance profiles in childhood lymphoblastic and non-lymphoblastic leukemia: a preliminary report. Leukemia 1994;8:1224-9.
12. Wang E, Miller LD, Ohnmacht GA, Liu ET, Marincola FM. High-fidelity mRNA amplification for gene profiling. Nat Biotechnol 2000;18:457-9.
13. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995;270:467-70.
14. Eisen MB, Spellman PT, Brown PO, Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998;95:14863-8.
15. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
16. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
17. Fine BM, Stanulla M, Schrappe M, et al. Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. Blood 2004;103:1043-9.
18. Hutson RG, Kitoh T, Moraga Amador DA, et al. Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells. Am J Physiol 1997;272:C1691-9.
19. Gasch AP, Spellman PT, Kao CM, et al. Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell 2000;11:4241-57.
20. Natarajan K, Meyer MR, Jackson BM, et al. Transcriptional profiling shows that Gcn4p is a master regulator of gene expression during amino acid starvation in yeast. Mol Cell Biol 2001;21:4347-68.
21. Gazzola GC, Dall'Asta V, Guidotti GG. Adaptive regulation of amino acid transport in cultured human fibroblasts. Sites and mechanism of action. J Biol Chem 1981;256:3191-8.
22. Marten NW, Burke EJ, Hayden JM, Straus DS. Effect of amino acid limitation on the expression of 19 genes in rat hepatoma cells. FASEB J 1994;8:538-44.
23. Bruhat A, Jousse C, Wang XZ, et al. Amino acid limitation induces expression of CHOP, a CCAAT/enhancer binding protein-related gene, at both transcriptional and post-transcriptional levels. J Biol Chem 1997;272:17588-93.
24. Aslanian AM, Kilberg MS. Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells. Biochem J 2001;358:59-67.
25. Yang XM, MacKenzie RE. NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is the mammalian homolog of the mitochondrial enzyme encoded by the yeast MIS1 gene. Biochemistry 1993;32:11118-23.
26. Di Pietro E, Sirois J, Tremblay ML, MacKenzie RE. Mitochondrial NAD-dependent methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase is essential for embryonic development. Mol Cell Biol 2002;22:4158-66.
27. Capizzi RL, Summers WP, Bertino JR. L-Asparaginase induced alteration of amethopterin (methotrexate) activity in mouse leukemia L5178Y. Ann N Y Acad Sci 1971;186:302-11.
28. Hurwitz R, Hozier J, LeBien T, et al. Characterization of a leukemic cell line of the pre-B phenotype. Int J Cancer 1979;23:174-80.
29. Wlodarska I, Aventin A, Ingles-Esteve J, et al. A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia. Blood 1997;89:1716-22.
30. Rosenfeld C, Goutner A, Choquet C, et al. Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature 1977;267:841-3.
31. Uphoff CC, MacLeod RA, Denkmann SA, et al. Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia 1997;11:441-7.
32. Findley HW Jr, Cooper MD, Kim TH, Alvarado C, Ragab AH. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 1982;60:1305-9.
33. Barker PE, Carroll AJ, Cooper MD. t(1;19)(q23;p13) in pre-B acute lymphocytic leukemia cell line 697. Cancer Genet Cytogenet 1987;25:379-80.
34. Nourse J, Mellentin JD, Galili N, et al. Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell 1990;60:535-45.
35. Kamps MP, Murre C, Sun XH, Baltimore D. A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell 1990;60:547-55.
36. Jack I, Seshadri R, Garson M, et al. RCH-ACV: a lymphoblastic leukemia cell line with chromosome translocation 1;19 and trisomy 8. Cancer Genet Cytogenet 1986;19:261-9.
37. Ohyashiki K, Fujieda H, Miyauchi J, et al. Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3. Leukemia 1991;5:322-31.
38. Hunger SP, Ohyashiki K, Toyama K, Cleary ML. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 1992;6:1608-20.
39. Inaba T, Roberts WM, Shapiro LH, et al. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 1992;257:531-4.
40. Naumovski L, Morgan R, Hecht F, et al. Philadelphia chromosome-positive acute lymphoblastic leukemia cell lines without classical breakpoint cluster region rearrangement. Cancer Res 1988;48:2876-9.
41. Matsuo Y, Ariyasu T, Ohmoto E, Kimura I, Minowada J. Bi-phenotypic t(9;22)-positive leukemia cell lines from a patient with acute leukemia: NALM-20, established at the onset; and NALM-21, NALM-22 and NALM-23, established after relapse. Hum Cell 1991;4:335-8.
42. Matsuo Y, Drexler HG. Establishment and characterization of human B cell precursor-leukemia cell lines. Leuk Res 1998;22:567-79.
43. Pegoraro L, Matera L, Ritz J, et al. Establishment of a Ph1-positive human cell line (BV173). J Natl Cancer Inst 1983;70:447-53.
44. Hermans A, Gow J, Selleri L, et al. bcr-abl oncogene activation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia 1988;2:628-33.
45. Stong RC, Korsmeyer SJ, Parkin JL, Arthur DC, Kersey JH. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985;65:21-31.
46. Gu Y, Nakamura T, Alder H, et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992;71:701-8.
47. Lange B, Valtieri M, Santoli D, et al. Growth factor requirements of childhood acute leukemia: establishment of GM-CSF-dependent cell lines. Blood 1987;70:192-9.
48. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias. Cell 1992;71:691-700.
49. Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995;9:1783-6.